Jane Street’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Other funds holding BCYC
BBA
LFCM
Jane Street's BCYC Position: Q3 2026 in Review
Jane Street reduced its Bicycle Therapeutics (BCYC) stake by 83% in Q3 2026, selling an estimated $1.32M and leaving 65,575 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #9665.
Jane Street first reported a position in BCYC in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.66M in Q2 2026. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.
- Jane Street held 65,575 shares of Bicycle Therapeutics worth $241K as of Q3 2026.
- Jane Street sold 326,588 Bicycle Therapeutics shares in Q3 2026, an estimated $1.32M.
- Bicycle Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9665 holding.
- Jane Street first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 15 quarters since.
- Jane Street's Bicycle Therapeutics position peaked at $1.66M in Q2 2026.
- 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.